AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
GENERATION OF A TRANSGENIC MOUSE WITH LUNG-SPECIFIC OVEREXPRESSION OFTHE HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST PROTEIN
Authors: WILMOTT RW KITZMILLER JA FIEDLER MA STARK JM
Citation: Rw. Wilmott et al., GENERATION OF A TRANSGENIC MOUSE WITH LUNG-SPECIFIC OVEREXPRESSION OFTHE HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST PROTEIN, American journal of respiratory cell and molecular biology, 18(3), 1998, pp. 429-434
MAKING THE DIAGNOSIS OF CYSTIC-FIBROSIS
Authors: WILMOTT RW
Citation: Rw. Wilmott, MAKING THE DIAGNOSIS OF CYSTIC-FIBROSIS, The Journal of pediatrics, 132(4), 1998, pp. 563-565
USE OF BRONCHOALVEOLAR LAVAGE SEMIQUANTITATIVE CULTURES IN CYSTIC-FIBROSIS
Authors: BAUGHMAN RP KEETON DA PEREZ C WILMOTT RW
Citation: Rp. Baughman et al., USE OF BRONCHOALVEOLAR LAVAGE SEMIQUANTITATIVE CULTURES IN CYSTIC-FIBROSIS, American journal of respiratory and critical care medicine, 156(1), 1997, pp. 286-291
A PILOT-STUDY OF THE PREDICTIVE VALUE OF PLASMA TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-1-BETA FOR STREPTOCOCCUS-PNEUMONIAE BACTEREMIA IN FEBRILE CHILDREN
Authors: STRAIT RT RUDDY RM FRIEDLAND LR DUNCAN KM WILMOTT RW
Citation: Rt. Strait et al., A PILOT-STUDY OF THE PREDICTIVE VALUE OF PLASMA TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-1-BETA FOR STREPTOCOCCUS-PNEUMONIAE BACTEREMIA IN FEBRILE CHILDREN, Academic emergency medicine, 4(1), 1997, pp. 44-51
COMPARISON BETWEEN MORPHOLOGIC CHANGES SEEN ON HIGH-RESOLUTION CT ANDREGIONAL PULMONARY PERFUSION SEEN ON SPECT IN PATIENTS WITH CYSTIC-FIBROSIS
Authors: DONNELLY LF GELFAND MJ BRODY AS WILMOTT RW
Citation: Lf. Donnelly et al., COMPARISON BETWEEN MORPHOLOGIC CHANGES SEEN ON HIGH-RESOLUTION CT ANDREGIONAL PULMONARY PERFUSION SEEN ON SPECT IN PATIENTS WITH CYSTIC-FIBROSIS, Pediatric radiology, 27(12), 1997, pp. 920-925
SAFETY OF REPEATED INTERMITTENT COURSES OF AEROSOLIZED RECOMBINANT HUMAN DEOXYRIBONUCLEASE IN PATIENTS WITH CYSTIC-FIBROSIS
Authors: EISENBERG JD AITKEN ML DORKIN HL HARWOOD IR RAMSEY BW SCHIDLOW DV WILMOTT RW WOHL ME FUCHS HJ CHRISTIANSEN DH SMITH AL
Citation: Jd. Eisenberg et al., SAFETY OF REPEATED INTERMITTENT COURSES OF AEROSOLIZED RECOMBINANT HUMAN DEOXYRIBONUCLEASE IN PATIENTS WITH CYSTIC-FIBROSIS, The Journal of pediatrics, 131(1), 1997, pp. 118-124
PREDICTORS OF TOTAL-BODY BONE-MINERAL DENSITY IN NON-CORTICOSTEROID-TREATED PREPUBERTAL CHILDREN WITH JUVENILE RHEUMATOID-ARTHRITIS
Authors: HENDERSON CJ CAWKWELL GD SPECKER BL SIERRA RI WILMOTT RW CAMPAIGNE BN LOVELL DJ
Citation: Cj. Henderson et al., PREDICTORS OF TOTAL-BODY BONE-MINERAL DENSITY IN NON-CORTICOSTEROID-TREATED PREPUBERTAL CHILDREN WITH JUVENILE RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 40(11), 1997, pp. 1967-1975
SURFACTANT REPLACEMENT THERAPY FOR ADULT-RESPIRATORY-DISTRESS-SYNDROME IN CHILDREN
Authors: EVANS DA WILMOTT RW WHITSETT JA
Citation: Da. Evans et al., SURFACTANT REPLACEMENT THERAPY FOR ADULT-RESPIRATORY-DISTRESS-SYNDROME IN CHILDREN, Pediatric pulmonology, 21(5), 1996, pp. 328-336
AEROSOLIZED RECOMBINANT HUMAN DNASE IN HOSPITALIZED CYSTIC-FIBROSIS PATIENTS WITH ACUTE PULMONARY EXACERBATIONS
Authors: WILMOTT RW AMIN RS COLIN AA DEVAULT A DOZOR AJ EIGEN H JOHNSON C LESTER LA MCCOY K MCKEAN LP MOSS R NASH ML JUE CP REGELMANN W STOKES DC FUCHS HJ
Citation: Rw. Wilmott et al., AEROSOLIZED RECOMBINANT HUMAN DNASE IN HOSPITALIZED CYSTIC-FIBROSIS PATIENTS WITH ACUTE PULMONARY EXACERBATIONS, American journal of respiratory and critical care medicine, 153(6), 1996, pp. 1914-1917
SAFETY OF ADENOVIRUS-MEDIATED TRANSFER OF THE HUMAN CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR CDNA TO THE LUNGS OF NONHUMAN-PRIMATES
Authors: WILMOTT RW AMIN RS PEREZ CR WERT SE KELLER G BOIVIN GP HIRSCH R DEINOCENCIO J LU PR REISING SF YEI SP WHITSETT JA TRAPNELL BC
Citation: Rw. Wilmott et al., SAFETY OF ADENOVIRUS-MEDIATED TRANSFER OF THE HUMAN CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR CDNA TO THE LUNGS OF NONHUMAN-PRIMATES, Human gene therapy, 7(3), 1996, pp. 301-318
RESTING ENERGY-EXPENDITURE, PULMONARY INFLAMMATION, AND GENOTYPE IN THE EARLY COURSE OF CYSTIC-FIBROSIS
Authors: THOMSON MA WILMOTT RW WAINWRIGHT C MASTERS B FRANCIS PJ SHEPHERD RW
Citation: Ma. Thomson et al., RESTING ENERGY-EXPENDITURE, PULMONARY INFLAMMATION, AND GENOTYPE IN THE EARLY COURSE OF CYSTIC-FIBROSIS, The Journal of pediatrics, 129(3), 1996, pp. 367-373
AMINOGLYCOSIDES LOWER SERUM MAGNESIUM CONCENTRATIONS IN PATIENTS WITHCYSTIC-FIBROSIS - A RETROSPECTIVE STUDY
Authors: HOLBEN DH SMITH AM WILMOTT RW
Citation: Dh. Holben et al., AMINOGLYCOSIDES LOWER SERUM MAGNESIUM CONCENTRATIONS IN PATIENTS WITHCYSTIC-FIBROSIS - A RETROSPECTIVE STUDY, Journal of the American Dietetic Association, 95(10), 1995, pp. 1152-1154
PLASMA INTERLEUKIN-1-ALPHA AND INTERLEUKIN-1-BETA, TUMOR-NECROSIS-FACTOR-ALPHA, AND LIPOPOLYSACCHARIDE CONCENTRATIONS DURING PULMONARY EXACERBATIONS OF CYSTIC-FIBROSIS
Authors: WILMOTT RW FRENZKE M KOCIELA V PENG L
Citation: Rw. Wilmott et al., PLASMA INTERLEUKIN-1-ALPHA AND INTERLEUKIN-1-BETA, TUMOR-NECROSIS-FACTOR-ALPHA, AND LIPOPOLYSACCHARIDE CONCENTRATIONS DURING PULMONARY EXACERBATIONS OF CYSTIC-FIBROSIS, Pediatric pulmonology, 18(1), 1994, pp. 21-27
GENE-THERAPY FOR CYSTIC-FIBROSIS UTILIZING A REPLICATION DEFICIENT RECOMBINANT ADENOVIRUS VECTOR TO DELIVER THE HUMAN CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR CDNA TO THE AIRWAYS - A PHASE-I STUDY
Authors: WILMOTT RW WHITSETT JA TRAPNELL B WERT S BAUGHMAN R CUPPOLETTI J TOLSTOHEV P
Citation: Rw. Wilmott et al., GENE-THERAPY FOR CYSTIC-FIBROSIS UTILIZING A REPLICATION DEFICIENT RECOMBINANT ADENOVIRUS VECTOR TO DELIVER THE HUMAN CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR CDNA TO THE AIRWAYS - A PHASE-I STUDY, Human gene therapy, 5(8), 1994, pp. 1019-1057
IN-VIVO EVALUATION OF THE SAFETY OF ADENOVIRUS-MEDIATED TRANSFER OF THE HUMAN CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR CDNA TO THE LUNG
Authors: YEI SP MITTEREDER N WERT S WHITSETT JA WILMOTT RW TRAPNELL BC
Citation: Sp. Yei et al., IN-VIVO EVALUATION OF THE SAFETY OF ADENOVIRUS-MEDIATED TRANSFER OF THE HUMAN CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR CDNA TO THE LUNG, Human gene therapy, 5(6), 1994, pp. 731-744
IL-1 RECEPTOR ANTAGONIST (IRAP) INHIBITS IL-8 PRODUCTION IN A549 CELLS INFECTED WITH A REPLICATION DEFICIENT RECOMBINANT ADENOVIRUS
Authors: SCHWARZ YA AMIN RS TRAPNELL B WILMOTT RW
Citation: Ya. Schwarz et al., IL-1 RECEPTOR ANTAGONIST (IRAP) INHIBITS IL-8 PRODUCTION IN A549 CELLS INFECTED WITH A REPLICATION DEFICIENT RECOMBINANT ADENOVIRUS, The FASEB journal, 8(4), 1994, pp. 10000136-10000136
LATE EFFECTS OF BONE-MARROW TRANSPLANTATION ON PULMONARY-FUNCTION IN CHILDREN
Authors: KAPLAN EB WODELL RA WILMOTT RW LEIFER B LESSER ML AUGUST CS
Citation: Eb. Kaplan et al., LATE EFFECTS OF BONE-MARROW TRANSPLANTATION ON PULMONARY-FUNCTION IN CHILDREN, Bone marrow transplantation, 14(4), 1994, pp. 613-621
IL-1 RECEPTOR ANTAGONIST INHIBITS IL-8 PRODUCTION IN A549 CELLS INFECTED WITH A REPLICATION DEFICIENT RECOMBINANT ADENOVIRUS
Authors: SCHWARZ YA AMIN RS TRAPNELL B WILMOTT RW
Citation: Ya. Schwarz et al., IL-1 RECEPTOR ANTAGONIST INHIBITS IL-8 PRODUCTION IN A549 CELLS INFECTED WITH A REPLICATION DEFICIENT RECOMBINANT ADENOVIRUS, Pediatric research, 35(4), 1994, pp. 10000397-10000397
TRANSFER OF THE CFTR CDNA TO THE LUNG OF NONHUMAN-PRIMATES BY A RECOMBINANT ADENOVIRUS - A STUDY OF TOXICITY
Authors: WILMOTT RW AMIN RS PEREZ CR WERT SE WHITSETT JA TRAPNELL BC
Citation: Rw. Wilmott et al., TRANSFER OF THE CFTR CDNA TO THE LUNG OF NONHUMAN-PRIMATES BY A RECOMBINANT ADENOVIRUS - A STUDY OF TOXICITY, Pediatric research, 35(4), 1994, pp. 10000400-10000400
RECENT ADVANCES IN THE TREATMENT OF CYSTIC-FIBROSIS
Authors: WILMOTT RW FIEDLER MA
Citation: Rw. Wilmott et Ma. Fiedler, RECENT ADVANCES IN THE TREATMENT OF CYSTIC-FIBROSIS, The Pediatric clinics of North America, 41(3), 1994, pp. 431-451
PULMONARY-EMBOLISM IN CHILDREN
Authors: EVANS DA WILMOTT RW
Citation: Da. Evans et Rw. Wilmott, PULMONARY-EMBOLISM IN CHILDREN, The Pediatric clinics of North America, 41(3), 1994, pp. 569-584
THE PEDIATRIC CLINICS OF NORTH-AMERICA - RESPIRATORY MEDICINE-II - PREFACE
Authors: WILMOTT RW
Citation: Rw. Wilmott, THE PEDIATRIC CLINICS OF NORTH-AMERICA - RESPIRATORY MEDICINE-II - PREFACE, The Pediatric clinics of North America, 41(3), 1994, pp. 210000005-210000005
RESPIRATORY MEDICINE .1. PREFACE
Authors: WILMOTT RW
Citation: Rw. Wilmott, RESPIRATORY MEDICINE .1. PREFACE, The Pediatric clinics of North America, 41(2), 1994, pp. 180000009-180000009
ACQUISITION OF PSEUDOMONAS-CEPACIA AT SUMMER CAMPS FOR PATIENTS WITH CYSTIC-FIBROSIS
Authors: PEGUES DA CARSON LA TABLAN OC FITZSIMMONS SC ROMAN SB MILLER JM JARVIS WR SPOHN W DIAKEW D MCCOY K JOHNSON T WILMOTT RW KOCIELA VL BIVENS K KANGA JF CHRISTENSON J WOODS C REISMAN J CICCALETAYLOR L WILSON WM HENNESSEY R ECCELSTONE ER HUNTER E KEELY K
Citation: Da. Pegues et al., ACQUISITION OF PSEUDOMONAS-CEPACIA AT SUMMER CAMPS FOR PATIENTS WITH CYSTIC-FIBROSIS, The Journal of pediatrics, 124(5), 1994, pp. 694-702
EVALUATION OF THE EFFICACY OF AV1CF2-MEDIATED CFTR GENE-TRANSFER TO THE NONHUMAN PRIMATE LUNG IN-VIVO WITH RS-PCR
Authors: LU PY YEI SP LONG ZF WILMOTT RW WHITSETT JA TRAPNELL B
Citation: Py. Lu et al., EVALUATION OF THE EFFICACY OF AV1CF2-MEDIATED CFTR GENE-TRANSFER TO THE NONHUMAN PRIMATE LUNG IN-VIVO WITH RS-PCR, Clinical chemistry, 40(12), 1994, pp. 2340-2340
Risultati: 1-25 | 26-27